osthol has been researched along with Adenocarcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, WJ; Liang, YC; Lin, RJ; Lin, SY; Liu, LY | 1 |
Bai, KJ; Bien, MY; Chang, JH; Chen, CK; Chien, MH; Kao, SJ; Su, JL; Yang, SF; Yu, MC | 1 |
2 other study(ies) available for osthol and Adenocarcinoma
Article | Year |
---|---|
N-Hydroxycinnamide derivatives of osthole presenting genotoxicity and cytotoxicity against human colon adenocarcinoma cells in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Line, Tumor; Colonic Neoplasms; Coumarins; DNA Damage; Down-Regulation; G2 Phase Cell Cycle Checkpoints; Humans; Hydroxamic Acids; M Phase Cell Cycle Checkpoints; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Signal Transduction; Up-Regulation | 2013 |
Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression.
Topics: Adenocarcinoma; Binding Sites; Cell Line, Tumor; Cell Movement; Coumarins; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medicine, Chinese Traditional; Neoplasm Invasiveness; NF-kappa B; Promoter Regions, Genetic; RNA, Messenger | 2012 |